Used in research and development for targeting ELR+ CXC chemokines, which are involved in angiogenesis and inflammatory processes. This antibody helps modulate immune responses and inhibit tumor growth by blocking pro-angiogenic signals, making it valuable in oncology and autoimmune disease studies. It serves as a reference tool in assays to measure neutralizing activity against ELR+ chemokines, supporting drug development and validation in preclinical models.